作为随机对照试验 (ACUDPN) 的一部分,患者对糖尿病多神经病的针的经验 - 定性研究
Marie Bolster1,2, Joanna Dietzel3, Isabel Valentina Habermann3
1Institute of Social Medicine, Epidemiology and Health Economics, Charité- Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, Berlin, 10117, Germany. marie.bolster@charite.de.
BMC complementary medicine and therapies
|September 1, 2025
概括
患有糖尿病周围神经病变 (DPN) 的患者发现针是一种可接受和有效的治疗方法,大多数患者报告症状减轻. 许多人对目前的DPN护理感到不满,
科学领域:
- 整合和补充医学
- 神经学
- 治疗疼痛
背景情况:
- 糖尿病周围神经病变 (DPN) 显著影响患者的生活质量.
- 目前的DPN治疗方法往往让患者感到不满,
- 患者希望减少药物使用并改善DPN症状.
研究的目的:
- 探索患者对治疗的经验和动机.
- 在随机对照试验 (RCT) 中了解患者对针的看法.
- 评估针治疗DPN的可接受性和有效性.
主要方法:
- 使用半结构面试对10名DPN患者进行定性研究.
- 面对面或通过电话进行的采访.
- 探讨DPN患者的经验,先前的医疗护理和参与试验.
主要成果:
- 十分之九的参与者报告了针的积极经验.
- 在大多数参与者中,针导致了DPN症状的减轻.
- 针的接受度很高,特别是在旨在减少药物的患者中.
结论:
- 针被认为是DPN的可接受和有效治疗选择.
- 这些发现与随附的RCT的定量结果一致.
- 针可以提供一种有价值的补充治疗.
更多相关视频
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
1.8K
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
287
相关概念视频
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
